175 related articles for article (PubMed ID: 24474248)
1. Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service.
Downing NS; Ross JS
JAMA; 2014 Feb; 311(8):793-4. PubMed ID: 24474248
[No Abstract] [Full Text] [Related]
2. FDA to regulate direct-to-consumer genetic tests.
Brower V
J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
[No Abstract] [Full Text] [Related]
3. Withdrawal of Personal Genome Service.
van Rossum LG
JAMA; 2014 Jun; 311(23):2441. PubMed ID: 24938573
[No Abstract] [Full Text] [Related]
4. Withdrawal of Personal Genome Service--reply.
Downing NS; Ross JS
JAMA; 2014 Jun; 311(23):2441-2. PubMed ID: 24938574
[No Abstract] [Full Text] [Related]
5. 23andMe and the FDA.
Annas GJ; Elias S
N Engl J Med; 2014 Mar; 370(11):985-8. PubMed ID: 24520936
[No Abstract] [Full Text] [Related]
6. Regulators weigh risks of consumer genetic tests.
Schmidt C
Nat Biotechnol; 2008 Feb; 26(2):145-6. PubMed ID: 18259159
[No Abstract] [Full Text] [Related]
7. Science and regulation. Regulating direct-to-consumer personal genome testing.
McGuire AL; Evans BJ; Caulfield T; Burke W
Science; 2010 Oct; 330(6001):181-2. PubMed ID: 20929761
[No Abstract] [Full Text] [Related]
8. Europe to ban direct-to-consumer genetic tests?
Borry P
Nat Biotechnol; 2008 Jul; 26(7):736-7. PubMed ID: 18612288
[No Abstract] [Full Text] [Related]
9. FDA halts sale of genetic test sold to consumers.
McCarthy M
BMJ; 2013 Nov; 347():f7126. PubMed ID: 24284347
[No Abstract] [Full Text] [Related]
10. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
11. Truth in testing laws: a shot in the arm for designer gene tests.
van Voorhees A
Health Matrix Clevel; 2006; 16(2):797-829. PubMed ID: 16948256
[No Abstract] [Full Text] [Related]
12. FDA: Gene tests need premarket approval.
Kuehn BM
JAMA; 2010 Jul; 304(2):145. PubMed ID: 20628120
[No Abstract] [Full Text] [Related]
13. Direct-to-consumer genetic testing: learning from the past and looking toward the future.
Bair S
Food Drug Law J; 2012; 67(4):413-33, ii. PubMed ID: 24640615
[TBL] [Abstract][Full Text] [Related]
14. Which way for genetic-test regulation? Assign regulation appropriate to the level of risk.
Javitt G
Nature; 2010 Aug; 466(7308):817-8. PubMed ID: 20703288
[No Abstract] [Full Text] [Related]
15. Understanding FDA regulation of DTC genetic tests within the context of administrative law.
Wagner JK
Am J Hum Genet; 2010 Oct; 87(4):451-6. PubMed ID: 20920664
[TBL] [Abstract][Full Text] [Related]
16. Next-generation DNA sequencing, regulation, and the limits of paternalism: the next challenge.
Evans JP; Berg JS
JAMA; 2011 Dec; 306(21):2376-7. PubMed ID: 22147382
[No Abstract] [Full Text] [Related]
17. Standard issue.
Nature; 2010 Aug; 466(7308):797. PubMed ID: 20703263
[No Abstract] [Full Text] [Related]
18. Direct-to-consumer genetic testing: driving choice?
Knoppers BM; Avard D; Howard HC
Expert Rev Mol Diagn; 2010 Nov; 10(8):965-8. PubMed ID: 21080811
[No Abstract] [Full Text] [Related]
19. Marketing health care products on the Internet: a proposal for updated federal regulations.
Green K
Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278
[No Abstract] [Full Text] [Related]
20. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
Baird S
Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
